Jan Lukáš

1.7k total citations
56 papers, 1.3k citations indexed

About

Jan Lukáš is a scholar working on Physiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Jan Lukáš has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Physiology, 20 papers in Organic Chemistry and 15 papers in Molecular Biology. Recurrent topics in Jan Lukáš's work include Lysosomal Storage Disorders Research (42 papers), Carbohydrate Chemistry and Synthesis (18 papers) and Cellular transport and secretion (11 papers). Jan Lukáš is often cited by papers focused on Lysosomal Storage Disorders Research (42 papers), Carbohydrate Chemistry and Synthesis (18 papers) and Cellular transport and secretion (11 papers). Jan Lukáš collaborates with scholars based in Germany, Italy and United States. Jan Lukáš's co-authors include Arndt Rolfs, Anne‐Katrin Giese, Hermann Mascher, Ulrike Grittner, Maria Vittoria Cubellis, Giuseppina Andreotti, Wolfgang Meyer, Sabrina Eichler, Maria Monticelli and Mariateresa Allocca and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical Journal.

In The Last Decade

Jan Lukáš

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Lukáš Germany 19 904 435 338 326 323 56 1.3k
Wei‐Lien Chuang United States 18 797 0.9× 472 1.1× 371 1.1× 240 0.7× 240 0.7× 28 1.1k
Helena Poupětová Czechia 17 932 1.0× 302 0.7× 272 0.8× 407 1.2× 196 0.6× 40 1.1k
Laura Gort Spain 24 758 0.8× 629 1.4× 282 0.8× 221 0.7× 275 0.9× 67 1.3k
María Josep Coll Spain 19 703 0.8× 370 0.9× 153 0.5× 228 0.7× 218 0.7× 37 1.1k
Mina Mirzaian Netherlands 20 1.3k 1.5× 481 1.1× 533 1.6× 577 1.8× 451 1.4× 35 1.6k
Jakub Sikora Czechia 20 487 0.5× 507 1.2× 186 0.6× 182 0.6× 137 0.4× 48 1.1k
J. Ledvinová Czechia 20 1.4k 1.6× 500 1.1× 447 1.3× 616 1.9× 325 1.0× 53 1.7k
Tina Rozaklis Australia 17 659 0.7× 236 0.5× 253 0.7× 231 0.7× 145 0.4× 24 835
Andrés D. Klein Chile 20 802 0.9× 420 1.0× 330 1.0× 259 0.8× 140 0.4× 43 1.3k
Amparo Chabás Spain 26 1.4k 1.6× 727 1.7× 690 2.0× 435 1.3× 503 1.6× 90 1.8k

Countries citing papers authored by Jan Lukáš

Since Specialization
Citations

This map shows the geographic impact of Jan Lukáš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lukáš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lukáš more than expected).

Fields of papers citing papers by Jan Lukáš

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lukáš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lukáš. The network helps show where Jan Lukáš may publish in the future.

Co-authorship network of co-authors of Jan Lukáš

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lukáš. A scholar is included among the top collaborators of Jan Lukáš based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lukáš. Jan Lukáš is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horowitz, Mia, Volha Skrahina, Jan Lukáš, et al.. (2024). GBA1-Associated Parkinson’s Disease Is a Distinct Entity. International Journal of Molecular Sciences. 25(13). 7102–7102. 11 indexed citations
2.
Monticelli, Maria, Bruno Hay Mele, Mariateresa Allocca, et al.. (2023). Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease. International Journal of Molecular Sciences. 24(2). 1095–1095. 11 indexed citations
3.
Glaß, Hannes, et al.. (2023). Corrosion Products from Metallic Implants Induce ROS and Cell Death in Human Motoneurons In Vitro. Journal of Functional Biomaterials. 14(8). 392–392. 9 indexed citations
4.
Monticelli, Maria, Mariateresa Allocca, Andrea Bosso, et al.. (2022). Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones. International Journal of Molecular Sciences. 23(9). 5105–5105. 18 indexed citations
5.
Pantoom, Supansa, et al.. (2021). A molecular genetics view on Mucopolysaccharidosis Type II. Mutation Research/Reviews in Mutation Research. 788. 108392–108392. 13 indexed citations
6.
Maor, Gali, et al.. (2020). Misfolding of Lysosomal α-Galactosidase a in a Fly Model and Its Alleviation by the Pharmacological Chaperone Migalastat. International Journal of Molecular Sciences. 21(19). 7397–7397. 12 indexed citations
7.
Lukáš, Jan, et al.. (2020). <p>Involving Patient Groups in Drug Research: A Systematic Review of Reasons</p>. Patient Preference and Adherence. Volume 14. 587–597. 8 indexed citations
8.
Monticelli, Maria, Mariateresa Allocca, Bruno Hay Mele, et al.. (2020). Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations. International Journal of Molecular Sciences. 21(2). 489–489. 94 indexed citations
9.
10.
Escobar, Hugo Murua, et al.. (2020). Generation of induced pluripotent stem cell lines AKOSi002-A and AKOSi003-A from symptomatic female adults with Wilson disease. Stem Cell Research. 43. 101708–101708. 2 indexed citations
11.
Escobar, Hugo Murua, Jörn Bullerdiek, Ulrike Reuner, et al.. (2020). Generation of two induced pluripotent stem cell lines from a female adult homozygous for the Wilson disease associated ATP7B variant p.H1069Q (AKOSi008-A) and a healthy control (AKOSi009-A). Stem Cell Research. 49. 102079–102079. 2 indexed citations
12.
Lukáš, Jan, Claudia Cozma, Fan Yang, et al.. (2017). Glucosylsphingosine Causes Hematological and Visceral Changes in Mice—Evidence for a Pathophysiological Role in Gaucher Disease. International Journal of Molecular Sciences. 18(10). 2192–2192. 24 indexed citations
13.
Citro, Valentina, Jorge Peña‐García, Helena den-Haan, et al.. (2016). Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease. PLoS ONE. 11(10). e0165463–e0165463. 27 indexed citations
14.
Giese, Anne‐Katrin, Hermann Mascher, Ulrike Grittner, et al.. (2015). A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease. Orphanet Journal of Rare Diseases. 10(1). 96 indexed citations
15.
Lukáš, Jan, Muhammad Sharif, Chaonan Zheng, et al.. (2014). Enzyme Enhancers for the Treatment of Fabry and Pompe Disease. Molecular Therapy. 23(3). 456–464. 37 indexed citations
16.
Karg, Eszter, Sándor Túri, Gyula Wittmann, et al.. (2012). Newborn Screening for Lysosomal Storage Disorders in Hungary. JIMD Reports. 6. 117–125. 72 indexed citations
17.
Yan, Xin, Jan Lukáš, Martin Witt, et al.. (2011). Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse. Metabolic Brain Disease. 26(4). 299–306. 26 indexed citations
18.
Pospíchalová, Vendula, Jolana Turečková, Bohumil Fafílek, et al.. (2011). Generation of two modified mouse alleles of the Hic1 tumor suppressor gene. genesis. 49(3). 142–151. 16 indexed citations
19.
Hovakimyan, Marine, Oliver Stachs, Hermann Mascher, et al.. (2011). Morphological Alterations of the Cornea in the Mouse Model of Niemann–Pick Disease Type C1. Cornea. 30(7). 796–803. 2 indexed citations
20.
Lukáš, Jan & Robert E. Wheeler. (1966). Pompeii and Herculaneum. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐Lien Chuang Breakdown of academic impact, for papers by Helena Poupětová Breakdown of academic impact, for papers by Laura Gort Breakdown of academic impact, for papers by María Josep Coll Breakdown of academic impact, for papers by Mina Mirzaian Breakdown of academic impact, for papers by Jakub Sikora Breakdown of academic impact, for papers by J. Ledvinová Breakdown of academic impact, for papers by Tina Rozaklis Breakdown of academic impact, for papers by Andrés D. Klein Breakdown of academic impact, for papers by Amparo Chabás
Rankless by CCL
2026